American Society of peritoneal surface malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer-Reference-Cited by-同舟云学术

American Society of peritoneal surface malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer

Published:2014-07-08 Issue:7 Volume:110 Page:777-778
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Esquivel Jesus¹,Piso Pompiliu²,Verwaal Vic³,Bachleitner-Hofmann Thomas⁴,Glehen Olivier⁵,González-Moreno Santiago⁶,Deraco Marcello⁷,Pelz Joerg⁸,Alexander Richard⁹,Glockzin Gabriel¹⁰

Affiliation:

1. Department of Surgical Oncology; Cancer Treatment Centers of America; Philadelphia Pennsylvania

2. Division of Surgical Oncology; Hospital Barmherzige; Regensburg Germany

3. National Cancer Institute; Amsterdam The Netherlands

4. Vienna University Hospital; Vienna Australia

5. Department of Surgical Oncology; Centre Hospitalier Lyon-Sud; Pierre-Benite France

6. Department of Surgical Oncology; MD Anderson Cancer Center; Madrid Spain

7. Department of Surgery; National Cancer Institute; Milan Italy

8. Department of Surgery; University of Wuerzburg; Wuerzburg Germany

9. Department of Surgical Oncology; University of Maryland; Baltimore Maryland

10. Department of Surgical Oncology; Regensburg University Hospital; Regensburg Germany

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.23722/fullpdf

Reference5 articles.

1. Prognostic similarities and differences in optimally resected liver metastases and peritoneal metastases from colorectal cancers;Elias;Ann Surg,2014

2. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with, without targeted therapy;Klaver;EJSO,2012

3. Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States;Turaga;Ann Surg Oncol,2014

4. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patient's with Peritoneal carcinomatosis from gastric cancer: Final results of a phase III randomized clinical trial;Yang;Ann Surg Oncol,2011

5. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 patient with colorectal cancer;Esquivel;Ann Surg Oncol,2014

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer;Journal of Translational Medicine;2024-07-09

2. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Cancer with Peritoneal Metastasis: A Single-Center Cohort Study;Medicina;2024-06-27

3. Predicting Survival in Mucinous Adenocarcinoma of the Appendix: Demographics, Disease Presentation, and Treatment Methodology;Annals of Surgical Oncology;2024-06-14

4. Meeting actual benchmarks for short- and long-term outcomes after cytoreductive surgery for peritoneal surface malignancy at a newly established academic treatment center;Surgery;2023-08

5. Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement;Clinical and Translational Oncology;2023-05-04